Clinical characteristics of malignant ovarian germ cell tumors

被引:0
作者
Zhang, Na [1 ]
Zhao, Jianguo [1 ]
Wang, Yue [2 ]
Qu, Pengpeng [1 ]
机构
[1] Tianjin Cent Hosp Gynecol Obstet, Dept Gynecol Oncol, 156 Nankai Three Rd, Tianjin 300100, Peoples R China
[2] Tianjin Cent Hosp Gynecol Obstet, Dept Obstet, Tianjin, Peoples R China
来源
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE | 2017年 / 10卷 / 07期
关键词
Malignant ovarian germ cell tumors; clinical characteristics; treatment; prognosis; RECURRENCE; FERTILITY; CANCER;
D O I
暂无
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
This study was aimed to investigate the clinical characteristics, treatment and prognosis effect of malignant ovarian germ cell tumors (MOGCTs). A total of 39 patients with MOGCTs treated at Gynecology Obstetrics in Tianjin Central Hospital were enrolled from January 1999 to November 2009 in this study. All the patients underwent pathological examination and diagnosis was confirmed. We used univariate and multivariate logistic regression analysis to evaluate influencing factors, and Kaplan-Meier survival analysis and cox promotional hazard regression analysis were used to evaluate the survival rate. All of patients were followed up until November 30, 2014. Eight cases (20.5%) were dead. Six months were the shortest survival time and this patient with IV stage yolk sac tumor was ill-controlled after operation, progressing to death rapidly. In respect of surgical procedures, 5 cases in pregnant group underwent laparotomy and 3 cases underwent laparoscope; In unpregnancy group, 3 cases underwent laparotomy and 3 cases underwent laparoscope. There were no significant differences between two groups (P=1.000). Seven cases in pregnant group received chemotherapy and one didn't. In unpregnancy group, all the 6 cases received chemotherapy. The chemotherapy regimen was BEP (bleomycin, etoposide and cisplatine) and 4 courses were used. There were no significant differences between two groups (P=1.000). Kaplan-Meier survival analysis showed no significant differences in the impact of Federation of Gynecology and Obstetrics (FIGO) I-II staging on survival prognosis (P > 0.05), however, manifesting significant differences were found when compared to stage IV respectively (I vs IV, X-2=27.072, P < 0.001; II vs IV, X-2=6.983, P=0.008; III vs IV, X-2=10.671, P=0.001) and between stage I and stage III (X-2=4.965, P=0.026). The result of Cox regression identified only MOGCT histological type as a predictor of overall survival (OS, Wald=6.240, P=0.012). For pregnancy analysis, univariate logistic regression analysis showed that no significant difference was found between pregnancy group and non-pregnancy (Wald=2.410, P=0.121). A multivariate logistic regression analysis also showed no statistical differences between two groups. FIGO staging and MOGCT histological type are critical factors affecting the prognosis of the patients with MOGCTs. The pregnant outcome of the patients receiving chemotherapy is desirable, and there are no significant effects of age, surgical-pathological staging, MOGCT histological type, surgical procedures and tumor size on the pregnancy outcome.
引用
收藏
页码:10874 / 10881
页数:8
相关论文
共 18 条
  • [1] Outcome of 3-day bleomycin, etoposide and cisplatin chemotherapeutic regimen for patients with malignant ovarian germ cell tumours: A Taiwanese Gynecologic Oncology Group study
    Chen, Chi-An
    Lin, Hao
    Weng, Chia-Sui
    Wen, Kuo-Chang
    Lu, Chien-Hsing
    Chou, Hung-Hsueh
    Huang, Yu-Fang
    Kang, Chieh-Yi
    Ho, Chih-Ming
    Yu, Mu-Hsien
    Chou, Cheng-Yang
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (18) : 3161 - 3167
  • [2] Fan XH, 2015, INT J CLIN EXP MED, V8, P19928
  • [3] Fawzy Amal, 2016, Asian Pac J Cancer Prev, V17, P323
  • [4] Nuclear expression of survivin portends a poor prognosis in Merkel cell carcinoma
    Kim, Jinah
    McNiff, Jennifer M.
    [J]. MODERN PATHOLOGY, 2008, 21 (06) : 764 - 769
  • [5] Liu Y, 2012, ZHONGHUA FU CHAN KE, V47, P40
  • [6] Outcome and Risk Factors for Recurrence in Malignant Ovarian Germ Cell Tumors A MITO-9 Retrospective Study
    Mangili, Giorgia
    Sigismondi, Cristina
    Gadducci, Angiolo
    Cormio, Gennaro
    Scollo, Paolo
    Tateo, Saverio
    Ferrandina, Gabriella
    Greggi, Stefano
    Candiani, Massimo
    Lorusso, Domenica
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2011, 21 (08) : 1414 - 1421
  • [7] Ovarian cancer mimics: how to avoid being fooled by extraovarian pelvic masses
    Masch, William R.
    Kamaya, Aya
    Wasnik, Ashish P.
    Maturen, Katherine E.
    [J]. ABDOMINAL RADIOLOGY, 2016, 41 (04) : 783 - 793
  • [8] Nagai Yutaka, 2012, Nihon Rinsho, V70 Suppl 4, P648
  • [9] Benign vaginal bleeding in 24 prepubertal patients: clinical, biochemical and imaging features
    Nella, Aikaterini A.
    Kaplowitz, Paul B.
    Ramnitz, Mary Scott
    Nandagopal, Radha
    [J]. JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2014, 27 (9-10) : 821 - 825
  • [10] Significance of the Complete Surgical Staging of Stage I Malignant Ovarian Germ Cell Tumors
    Park, Jeong-Yeol
    Kim, Dae-Yeon
    Suh, Dae-Shik
    Kim, Jong-Hyeok
    Kim, Yong-Man
    Kim, Young-Tak
    Nam, Joo-Hyun
    [J]. ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (09) : 2982 - 2987